Democritus University of Thrace (DUTH)
The effect of general anesthesia in the immunological response of breast cancer patients
Abstract
dc:descriptionThis study investigates the impact of general anesthesia on the immune response in breast cancer patients undergoing surgical treatment. The focus is on how different opioid agents used during anesthesia—namely fentanyl and remifentanil—might modulate immunological parameters that could potentially influence tumor progression or recurrence. The immune system plays a pivotal role in cancer control, and its suppression during the perioperative period may facilitate cancer dissemination. This study reviews the mechanisms of anti-tumor immunity, including the roles of cytotoxic CD8+ T-cells, helper CD4+ T-cells, and regulatory T-cells (Tregs), and how these are influenced by anesthetic agents and surgical stress. Literature indicates that volatile anesthetics and opioids can suppress immune function and enhance pro-tumor pathways through increased expression of inflammatory cytokines and angiogenic factors. On the other hand, local anesthetics may offer potential anti-cancer effects.The study involved 30 female patients with histologically confirmed breast cancer, divided into two groups based on the opioid used. Blood samples were collected before and 24 hours after surgery to assess white blood cells, lymphocyte subpopulations (CD4+, CD8+, Tregs), and the CD4/CD8 ratio. The results showed a significant increase in total white blood cells and a reduction in lymphocytes postoperatively. The duration of anesthesia had a stronger effect than the choice of opioid; longer procedures were associated with greater lymphopenia and CD4+ T-cell decrease. No significant differences were found in Treg levels across groups or durations. In conclusion, the type and duration of anesthesia may influence postoperative immune suppression. Shorter procedures with careful selection of anesthetic drugs may help preserve immune function in breast cancer patients. The findings support a tailored anesthetic approach in oncologic surgery to minimize immunosuppressive effects and potentially improve long-term outcomes.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lyronis, Grigorios
- Λυρώνης, Γρηγόριος
Subjects
dc:subject × 18- Αναισθησία και ανοσολογία του καρκίνου
- Καρκίνος και αναισθησιολογικοί παράγοντες
- Αναισθησιολογία και ανάπτυξη του όγκου
- Anaesthesia and immunity in cancer
- Cancer and anaesthetic agents
- Anaesthesia and tumour progression
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Αναισθησιολογία και Ιατρική πόνου
- Ογκολογία
- Βασική Ιατρική
- Ανοσολογία
- Clinical Medicine
- Medical and Health Sciences
- Anesthesiology and Pain Medicine
- Oncology
- Basic Medicine
- Immunology
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59949